EFPIA disclosure
.
Search
“LastMile” – improving through digital
“LastMile” – improving through digital
Boehringer Ingelheim Empowers 380 Regional Experts with Latest Insights in Cardio-Renal-Metabolic Care
Boehringer Ingelheim hosted the ‘CRM 360 standalone meeting’, ‘IMETA CRM Discussions for EXperts (MEDEX)’, to discuss the latest advances in the management of cardio-renal-metabolic conditions
Elevating Cardio-Renal-Metabolic Care: Boehringer Ingelheim Imparts Latest Insights to 400 Regional Experts
Boehringer Ingelheim hosted the ‘CRM Summit’ to facilitate exchanges and discussions on the latest advances in the management of cardiovascular, renal, and metabolic diseases to help improve patient outcomes across India, the Middle East and Africa
Fabio Paganini fostering inclusion & agility in AH
How employees are contributing to an inclusive culture at Boehringer Ingelheim.
Vision & Values
Vision & Values
‘Angels’ Initiative is Launched to Deliver Medical Education on Stroke Management at University
‘Angels’ Initiative is Launched to Deliver Medical Education on Stroke Management at University Hospitals
Boehringer Ingelheim Recognized As Global Top Employer for 2021
Boehringer Ingelheim Recognized As Global Top Employer for 2021
History video
Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim
CENTRAGARD internal parasite protection for cats in US
Centragard, an innovative product to treat heartworm disease in cats, launched in the U.S.
The power of our people
Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity.
Boehringer Ingelheim Announces $1.14 Million Support for Lebanon
Boehringer Ingelheim Announces $1.14 Million Support for Lebanon
Boehringer Ingelheim inaugurates new milestone on its long-term commitment to the Kingdom
Boehringer Ingelheim inaugurates new milestone on its long-term commitment to the Kingdom
Patient Organizations
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations.
More than 140 healthcare professionals gather at 3rd edition of Interstitial Lung Disease Summit to discuss latest scientific guidelines
The ILD summit discussed the latest treatment guidelines for ILD which vastly impacts quality of life
From prevention to prediction
What's the future of livestock farming?
Metabolic Diseases
Metabolic Diseases
Science Focus
Science Focus
Boehringer Ingelheim Brings Hundreds of Leading Cardiologists from Eight Countries Together
Boehringer Ingelheim Brings Hundreds of Leading Cardiologists from Eight Countries Together
Skin Diseases
Skin Diseases
Boehringer Ingelheim Builds on 100 Years of Expertise To Continue Raising Awareness of Respiratory
Boehringer Ingelheim Builds on 100 Years of Expertise To Continue Raising Awareness of Respiratory Diseases
Boehringer Ingelheim Saudi Arabia Recognized as ‘Top Employer for 2021’ by The Top Employers Institute
Boehringer Ingelheim Saudi Arabia Recognized as ‘Top Employer for 2021’ by The Top Employers Institute
Boehringer Ingelheim Saudi Arabia Hosts Virtual Summit on the Latest Updates in Diabetes, Cardio
Boehringer Ingelheim Saudi Arabia Hosts Virtual Summit on the Latest Updates in Diabetes, Cardio-Metabolism, Respiratory Diseases and Stroke Management
The UAE MOHAP Approves the First and Only Therapy for the Treatment of Adult Generalized Pustular Psoriasis Flares
The first treatment of its kind in the UAE by Boehringer Ingelheim is the only FDA and EMA-approved medication used to treat GPP flares in adult patients and works to help block a source of inflammation that may cause GPP flares
EFPIA Mission Possible
This new video highlights how treatments once known for type 2 diabetes are now helping to prevent heart failure, stroke or kidney disease.